Literature DB >> 16040222

Physico-chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes.

Luciana M A Pinto1, Leonardo Fernandes Fraceto, Maria Helena A Santana, Thelma A Pertinhez, Sérgio Oyama Junior, Eneida de Paula.   

Abstract

Local anesthetics are able to induce pain relief by binding to the sodium channel of excitable membranes, blocking the influx of sodium ions and the propagation of the nervous impulse. Benzocaine (BZC) is a local anesthetic whose low water-solubility limits its application to topical formulations. The present work focuses on the characterization of inclusion complexes of BZC in beta-cyclodextrin (beta-CD). Differential scanning calorimetry and electron microscopy gave evidences of the formation and the morphology of the complex. Fluorescence spectroscopy showed a BZC/beta-CD 1:1 stoichiometry. Phase-solubility diagrams allowed the determination of the association constants between BZC and beta-CD (549 M(-1)) and revealed that a three-fold increase in BZC solubility can be reached upon complexation with beta-CD. The details of BZC/beta-CD molecular interaction were analyzed by 1H 2D NMR allowing the proposition of an inclusion model for BZC into beta-CD where the aromatic ring of the anesthetic is located near the head of the beta-CD cavity. Moreover, in preliminary toxicity studies, the complex seems to be less toxic than BZC alone, since it induced a decrease in the in vitro oxidation of human hemoglobin. These results suggest that the BZC/beta-CD complex represents an effective novel formulation to enhance BZC solubility in water, turning it promising for use outside its traditional application, i.e., in infiltrative anesthesia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040222     DOI: 10.1016/j.jpba.2005.06.010

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Comparison of antinociceptive effects of plain lidocaine versus lidocaine complexed with hydroxypropyl-β-cyclodextrin in animal models of acute and persistent orofacial pain.

Authors:  Stéphani Batista de Oliveira; Erika Ivanna Araya; Eder Gambeta; Luiz Eduardo Nunes Ferreira; Michele Franz-Montan; Rafaela Franco Claudino; Juliana Geremias Chichorro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-06       Impact factor: 3.000

2.  Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity.

Authors:  Nathalie Ferreira Silva de Melo; Renato Grillo; Viviane Aparecida Guilherme; Daniele Ribeiro de Araujo; Eneida de Paula; André Henrique Rosa; Leonardo Fernandes Fraceto
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

3.  Structure confirmation and thermal kinetics of the inclusion of cis-jasmone in β-cyclodextrin.

Authors:  Lvye Ai; Jingyan Hu; Xiaoming Ji; Huaxin Zhao
Journal:  RSC Adv       Date:  2019-08-21       Impact factor: 4.036

4.  Using ß-cyclodextrin and Arabic Gum as Wall Materials for Encapsulation of Saffron Essential Oil.

Authors:  Mohsen Atefi; Kooshan Nayebzadeh; Abdorreza Mohammadi; Amir Mohammad Mortazavian
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

5.  Cellulose-Cyclodextrin Co-Polymer for the Removal of Cyanotoxins on Water Sources.

Authors:  Diego Gomez-Maldonado; Iris Beatriz Vega Erramuspe; Ilari Filpponen; Leena-Sisko Johansson; Salvatore Lombardo; Junyong Zhu; Wim Thielemans; Maria S Peresin
Journal:  Polymers (Basel)       Date:  2019-12-12       Impact factor: 4.329

6.  Application of nanogel systems in the administration of local anesthetics.

Authors:  Jeremy Pk Tan; Maureen Bh Tan; Michael Kc Tam
Journal:  Local Reg Anesth       Date:  2010-09-01

7.  Preparation, Characterization, and Pharmacological Activity of Cymbopogon winterianus Jowitt ex Bor (Poaceae) Leaf Essential Oil of β-Cyclodextrin Inclusion Complexes.

Authors:  Priscila L Santos; Adriano A S Araújo; Jullyana S S Quintans; Makson G B Oliveira; Renan G Brito; Mairim R Serafini; Paula P Menezes; Marcio R V Santos; Pericles B Alves; Waldecy de Lucca Júnior; Arie F Blank; Viviana La Rocca; Reinaldo N Almeida; Lucindo J Quintans-Júnior
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.